69 related articles for article (PubMed ID: 2864736)
1. Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers.
Puşcas I; Reznicek A; Moldovan A; Puşcaş C; Sturzu L
Med Interne; 1985; 23(3):185-9. PubMed ID: 2864736
[TBL] [Abstract][Full Text] [Related]
2. Effect of verapamil on purified bovine carbonic anhydrase. An in vitro study.
Puscas I; Búzás G; Sturzu L; Vălean S
Arzneimittelforschung; 1984; 34(9):946-7. PubMed ID: 6542373
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action.
Puscas I; Ifrim M; Maghiar T; Coltau M; Domuta G; Baican M; Hecht A
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):265-70. PubMed ID: 11430635
[TBL] [Abstract][Full Text] [Related]
4. Effect of ZnSO4 upon gastric acid secretion and carbonic anhydrase.
Puscas I; Sturzu L; Búzás G
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):609-12. PubMed ID: 4077313
[TBL] [Abstract][Full Text] [Related]
5. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
6. Catecholamine-induced vasoconstriction is sensitive to carbonic anhydrase I activation.
Puscas I; Coltau M; Gilau L; Pasca R; Domuta G; Baican M; Hecht A
Braz J Med Biol Res; 2001 Mar; 34(3):339-45. PubMed ID: 11262584
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
8. [Activation of carbonic anhydrase from rat gastric tissue as a result of phosphorylation by 3',5'-AMP-dependent protein kinase].
Bersimbaev RI; Konstantinov YM; Arguyinskaya SV; Salganik RI
Biokhimiia; 1975; 40(3):570-7. PubMed ID: 173424
[TBL] [Abstract][Full Text] [Related]
9. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
10. Beta-agonist-induced constitutive beta(2)-adrenergic receptor activity in bovine tracheal smooth muscle.
de Vries B; Meurs H; Roffel AF; Elzinga CR; Hoiting BH; de Vries MM; Zaagsma J
Br J Pharmacol; 2000 Nov; 131(5):915-20. PubMed ID: 11053211
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
[TBL] [Abstract][Full Text] [Related]
12. [Effect of beta adrenergic receptor agonists and blockaders on the action of bradykinin].
Shvarts GIa
Biull Eksp Biol Med; 1981 Nov; 92(11):575-6. PubMed ID: 6119126
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine, the most potent ulcerogenic drug known so far, powerfully activates carbonic anhydrase I, II and IV. In vitro and in vivo studies.
Puscas I; Coltau M; Maghiar A; Domuta G
Exp Toxicol Pathol; 2000 Oct; 52(5):431-5. PubMed ID: 11089894
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenoceptor-mediated inhibition of alpha 1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig.
Haynes JM; Hill SJ
Br J Pharmacol; 1997 Nov; 122(6):1067-74. PubMed ID: 9401771
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic and beta-adrenergic effects on gastric antral motility.
Bech K; Hovendal CP; Gottrup F; Andersen D
Scand J Gastroenterol Suppl; 1984; 89():65-70. PubMed ID: 6146195
[TBL] [Abstract][Full Text] [Related]
18. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Shulkin BL; Peele ME; Utiger RD
Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
